Search over 3,000 reports

    Xeristar- Drug Insight, 2017

    Xeristar- Drug Insight, 2017
    Date: Jan, 2018
    Type: Pharmaceutical Industry Report
    Pages: 35
    Geography: Global
    Delivery Timeline: 48 hours
    SKU: DIDI0315
    "Xeristar - Drug Insight, 2018" report by DelveInsight provides comprehensive information of the drug, Xeristar. It includes Xeristar`s overview, mechanism, clinical trials, regulatory milestones, deals & partnerships. It further provides Xeristar`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted sales of Xeristar till 2020. The report also throws light on Xeristar`s market competition and emerging therapies in the same space as Xeristar. A SWOT analysis of Xeristar is also featured.
    * Depending on information availability

    Methodology
    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report
    • A comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
    • Patent information around Xeristar in United States (US) and Europe (EU) has been highlighted
    • API manufacturers for Xeristar in United States, Europe, China and India
    • The report contains historical and forecasted sales for Xeristar till 2020
    • Comprehensive coverage of the emerging therapies (Phase III) in the space where Xeristar operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
    • The report also features the SWOT analysis of Xeristar

    Reasons to Buy
    • Establish a comprehensive understanding of the drug, Xeristar
    • Access to Xeristar`s API manufacturers details to devise API procurement strategy for generic development
    • Plan developmental timelines around Xeristar`s patents for the major markets- US and EU
    • Understand Xeristar`s current and future growth through its historical and forecasted sales
    • Identify and understand the current in-market competitors for Xeristar
    • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
    • Identify and plan ahead for prospective emerging players and their products operating in the same space as Xeristar
    • Identify opportunities in the same area as Xeristar with DelveInsight`s SWOT analysis
    1. Report Introduction
    2. Xeristar - Overview
    • Product Description
    • Route of Synthesis
    • Mechanism of Action
    • Pharmacology
    • Pharmacodynamics
    • Pharmacokinetics
    • Adverse Reactions
    • Clinical Trials
    • Regulatory Milestones
    • Product Development Activities
    3. Global API Manufacturers
    • United States
    • Europe
    • China
    • India
    4. Product Details
    • United States
    • Europe
    5. Xeristar Global Sales Assessment
    • Historical Global Sales
    • Forecasted Global Sales
    6. Patent Details
    7. Market Competition
    8. Emerging Therapies
    8.1. Drug name: Company name
    • Product Description
    • Research & Development
    • Product Development Activities
    Other product profiles in the detailed report…..
    9. SWOT Analysis
    Appendix
    Methodology
    Consulting Services
    About DelveInsight
    Contact Us
    Disclaimer
    Note: Certain sections of the table of contents would vary according to the availability of information
    Table 1: Xeristar, Description
    Table 2: API Manufacturers Region wise
    Table 3: API Manufacturers for United States
    Table 4: API Manufacturers for Europe
    Table 5: API Manufacturers for China
    Table 6: API Manufacturers for India
    Table 7: Xeristar Product Details, United States
    Table 8: Xeristar Product Details, Europe
    Table 9: Xeristar, Historical Global Sales till 2017 (in million USD)
    Table 10: Xeristar, Forecasted Global Sales from 2018-2020 (in million USD)
    Table 11: Patent Details: Xeristar
    Table 12: Xeristar Major Competitors
    Table 13: Emerging Therapies
    Figure 1: Xeristar
    Figure 2: Xeristar, Historical Global Sales till 2017 (in million USD)
    Figure 3: Xeristar, Forecasted Global Sales from 2018-2020 (in million USD)
    Figure 4: Patent Details: Xeristar
    Figure 5: API Manufacturers Region wise
    Xeristar

    Xeristar Marketed Drugs Overview

    Xeristar Market Assessment

    Xeristar API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers

    Xeristar US DMF

    Xeristar US Drug Master Files

    Xeristar Active Substance Master File/ EUDMF

    Xeristar Generic players

    Xeristar Patent Expiration

    Xeristar Patent Exclusivity

    Xeristar API Manufacturers

    Xeristar Global Forecasted Sales Figure

    Xeristar API Route of Synthesis

    Xeristar Market sales

    Xeristar SWOT Analysis

    Xeristar Pipeline

    • Single User License
      (20% Off)
      $1,000.00
    • Site License
      (30% Off)
      $2,000.00
    • Global License
      (40% Off)
      $3,000.00

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap